| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
110.12(B) |
| Last
Volume: |
7,714,820 |
Avg
Vol: |
8,368,014 |
| 52
Week Range: |
$48.64 - $77.71 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
421,705 |
996,293 |
2,118,674 |
| Total Sell Value |
$22,679,618 |
$30,048,564 |
$60,765,476 |
$110,963,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
25 |
43 |
79 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nicholas Peter M |
Director |
– • – |
2009-03-03 |
4 |
AS |
$6.77 |
$396,801 |
D/D |
(58,577) |
12,339,307 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-03-03 |
4 |
AS |
$6.78 |
$1,017,000 |
D/D |
(150,000) |
29,058,029 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-03-02 |
4 |
AS |
$6.69 |
$1,199,943 |
I/I |
(179,471) |
16,250,561 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2009-03-02 |
4 |
AS |
$6.69 |
$438,983 |
D/D |
(65,657) |
12,397,884 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-03-02 |
4 |
AS |
$6.75 |
$1,012,800 |
D/D |
(150,000) |
29,208,029 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-02-24 |
4 |
S |
$8.23 |
$1,646,000 |
D/D |
(200,000) |
29,358,029 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-02-23 |
4 |
S |
$8.26 |
$825,500 |
D/D |
(100,000) |
29,558,029 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-02-20 |
4 |
S |
$8.36 |
$1,462,650 |
D/D |
(175,000) |
29,658,029 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-02-19 |
4 |
S |
$8.66 |
$1,948,275 |
D/D |
(225,000) |
29,833,029 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-02-18 |
4 |
S |
$8.45 |
$1,267,800 |
D/D |
(150,000) |
30,058,029 |
|
- |
|
| Baim Donald S |
EVP, Chief Med. & Sci. Officer |
• – – |
2009-02-13 |
4 |
D |
$8.66 |
$28,916 |
D/D |
(3,339) |
40,381 |
|
- |
|
| Baim Donald S |
EVP, Chief Med. & Sci. Officer |
• – – |
2009-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,514 |
43,720 |
|
- |
|
| Abele John E |
Director |
– • – |
2009-02-13 |
4 |
S |
$8.91 |
$1,559,775 |
D/D |
(175,000) |
30,208,029 |
|
- |
|
| Mcconnell William F Jr |
SVP, Administration CRM |
• – – |
2009-02-13 |
4 |
D |
$8.66 |
$28,093 |
D/D |
(3,244) |
59,165 |
|
- |
|
| Mcconnell William F Jr |
SVP, Administration CRM |
• – – |
2009-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,514 |
62,409 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2009-02-13 |
4 |
D |
$8.66 |
$5,941 |
D/D |
(686) |
12,861 |
|
- |
|
| Onuscheck John Michael |
SVP & Pres-Neuromodulation |
• – – |
2009-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,635 |
13,547 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2009-02-12 |
4/A |
D |
$8.80 |
$8,369 |
D/D |
(951) |
13,859 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2009-02-12 |
4 |
D |
$8.80 |
$9,337 |
D/D |
(1,061) |
25,332 |
|
- |
|
| Mcfaul David W |
Senior VP International |
• – – |
2009-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,795 |
26,393 |
|
- |
|
| Colen Fred |
President, CRM |
• – – |
2009-02-12 |
4 |
D |
$8.80 |
$58,599 |
D/D |
(6,659) |
33,849 |
|
- |
|
| Colen Fred |
President, CRM |
• – – |
2009-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,469 |
40,508 |
|
- |
|
| Baim Donald S |
EVP, Chief Med. & Sci. Officer |
• – – |
2009-02-12 |
4 |
D |
$8.80 |
$19,404 |
D/D |
(2,205) |
33,206 |
|
- |
|
| Baim Donald S |
EVP, Chief Med. & Sci. Officer |
• – – |
2009-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,990 |
35,411 |
|
- |
|
| Mcconnell William F Jr |
SVP, Administration CRM |
• – – |
2009-02-12 |
4 |
D |
$8.80 |
$36,863 |
D/D |
(4,189) |
51,895 |
|
- |
|
2009 Records found
|
|
Page 64 of 81 |
|
|
0.01 (0.01%) 
